Name: Tyrosine Kinase Inhibitors Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMPH1280
Price: 4350 USD
Availability: InStock

Tyrosine Kinase Inhibitors Market Size Share Growth Opportunities and Forecast 2022

Tyrosine Kinase Inhibitors Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Tyrosine Kinase Inhibitors Market is segmented&nbsp;By Product Type (Receptor Tyrosine Kinase Inhibitor (RTKI) (Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, BCR-ABL Tyrosine Kinase Inhibitor, Others), Non- Receptor Tyrosine Kinase Inhibitors (n RTKI&rsquo;s)),&nbsp;By Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Others),&nbsp;By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others),&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global &quot;Tyrosine Kinase Inhibitors Market&quot;&nbsp;is expected to grow at a <a href="https://www.datamintelligence.com/download-sample/tyrosine-kinase-inhibitors-market">CAGR of 8%</a> during the forecasting period (2022-2029).
</blockquote>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/tylosin-market">Tylosin Market</a>

<a href="https://www.datamintelligence.com/research-report/pyridine-market">Pyridine Market</a>

<a href="https://www.datamintelligence.com/research-report/salivary-gland-cancer-treatment-market">Salivary Gland Cancer Treatment Market</a>

<h3>&nbsp;</h3>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

1. Methodology and Scope

1.1. Research Methodology

1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

3.1. Market Snippet by Product Type

3.2. Market Snippet by Application

3.3. Market Snippet by Distribution Channel

3.4. Market Snippet by Region

4. Market Dynamics

4.1. Market Impacting Factors

4.1.1. Drivers

4.1.1.1. High Cancer Prevalence

4.1.1.2. Increasing demand for Targeted Therapies

4.1.2. Restraints

4.1.2.1. Premium Drug Price

4.1.3. Opportunity

4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter&#39;s Five Forces Analysis

5.2. Regulatory Analysis

5.3. Patent Analysis

5.4. Epidemiology

5.5. Pipeline Analysis

6. By Product Type

6.1.1.&nbsp;Introduction

6.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

6.1.3. Market Attractiveness Index, By Product Type

6.2. Receptor Tyrosine Kinase Inhibitor (RTKI)

6.2.1. Introduction

6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

6.2.2.1. Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors

6.2.2.2. Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors

6.2.2.3. BCR-ABL Tyrosine Kinase Inhibitor

6.2.2.4. Others

6.3. Non- Receptor Tyrosine Kinase Inhibitors (n RTKI&rsquo;s)

7. By Application

7.1.1.&nbsp;Introduction

7.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

7.1.3. Market Attractiveness Index, By Application

7.2. Chronic Myeloid Leukemia (CML)

7.2.1. Introduction

7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

7.3.&nbsp;&nbsp;&nbsp;Lung Cancer

7.4. Breast Cancer

7.5.&nbsp;&nbsp;&nbsp;Renal Cell Cancer

7.6. Others

8. By Distribution Channel

8.1.1.&nbsp;Introduction

8.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

8.1.3. Market Attractiveness Index, By Distribution Channel

8.2.&nbsp;&nbsp;Retail Pharmacies

8.2.1. Introduction

8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

8.3.&nbsp;Hospital Pharmacies

8.4. Others&nbsp;

9. By Region

9.1. Introduction

9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

9.1.2. Market Attractiveness Index, By Region

9.2. North America

9.2.1. Introduction

9.2.2. Key Region-Specific Dynamics

9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.2.6.1. The U.S.

9.2.6.2. Canada

9.2.6.3. Mexico

9.3. Europe

9.3.1. Introduction

9.3.2. Key Region-Specific Dynamics

9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.3.6.1. Germany

9.3.6.2. The U.K.

9.3.6.3. France

9.3.6.4. Italy

9.3.6.5. Spain

9.3.6.6. Rest of Europe

9.4. South America

9.4.1. Introduction

9.4.2. Key Region-Specific Dynamics

9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.4.6.1. Brazil

9.4.6.2. Argentina

9.4.6.3. Rest of South America

9.5. Asia Pacific

9.5.1. Introduction

9.5.2. Key Region-Specific Dynamics

9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.5.6.1. China

9.5.6.2. India

9.5.6.3. Japan

9.5.6.4. Australia

9.5.6.5. Rest of Asia Pacific

9.6. Middle East &amp; Africa

9.6.1. Introduction

9.6.2. Key Region-Specific Dynamics

9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1.&nbsp;&nbsp;Competitive Scenario

10.2.&nbsp;Competitor&nbsp;Tyrosine Kinase Inhibitors Strategy Analysis

10.3. Comparative Product Portfolio Analysis

10.4. Market Positioning/Share Analysis

10.5. Mergers and Acquisitions Analysis

11. - Company Profiles

11.1. AstraZeneca Plc

11.1.1. Company Overview

11.1.2. Product Portfolio and Description

11.1.3. Key Highlights

11.1.4. Financial Overview

11.2. Bayer AG

11.3.&nbsp;Boehringer Ingelheim International GmbH

11.4.&nbsp;F. Hoffmann-La Roche Ltd.

11.5. Eisai Co., Ltd.

11.6. Eurofarma Laborat&oacute;rios S/A

11.7.&nbsp;Pfizer

11.8.&nbsp;Novartis

11.9.&nbsp;Bristol-Myers Squibb

11.10.&nbsp;Johnson &amp; Johnson

12. DataM Intelligence

12.1. Appendix

12.2. About Us and Services

12.3. Contact Us

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables and Figures</h2>

<h3>List of Tables</h3>

TABLE 01.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE, 2021, 2025 &amp; 2029 , BY PRODUCT TYPE, ($MILLION)

TABLE 02.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE 2021, 2025 &amp; 2029 , BY DISTRIBUTION CHANNEL, ($MILLION)

TABLE 03.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE 2021, 2025 &amp; 2029 , BY APPLICATION, ($MILLION)

TABLE 04.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE 2021, 2025 &amp; 2029 , BY REGION, ($MILLION)

TABLE 05.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET SHARE 2021, 2025 &amp; 2029 (%), BY PRODUCT TYPE ($MILLION)

TABLE 06.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

TABLE 07.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET SHARE 2021, 2025 &amp; 2029 (%), BY DISTRIBUTION CHANNEL ($MILLION)

TABLE 08.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY APPICATION, 2021&ndash;2029 ($MILLION)

TABLE 09.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET SHARE 2021, 2025 &amp; 2029 (%), BY APPLICATION ($MILLION)

TABLE 10.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 11.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET SHARE 2021, 2025 &amp; 2029 (%), BY REGION ($MILLION)

TABLE 12.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY REGION, 2021&ndash;2029 ($MILLION)

TABLE 13.&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

TABLE 14.&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

TABLE 15.&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 16.&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 17.&nbsp;&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

TABLE 18.&nbsp;&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

TABLE 19.&nbsp;&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 20.&nbsp;&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 21.&nbsp;&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET VALUE , BY PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

TABLE 22.&nbsp;&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET VALUE , BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

TABLE 23.&nbsp;&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 24.&nbsp;&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET VALUE , BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 25.&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET VALUE , BY PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

TABLE 26.&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET VALUE , BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

TABLE 27.&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 28.&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET VALUE , BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 29.&nbsp;&nbsp;&nbsp;MIDDLE EAST &amp; AFRICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

TABLE 30.&nbsp;&nbsp;&nbsp;MIDDLE EAST &amp; AFRICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

TABLE 31.&nbsp;&nbsp;&nbsp;MIDDLE EAST &amp; AFRICA TYROSINE KINASE INHIBITORS MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

&nbsp;

TABLE 32.&nbsp;&nbsp;&nbsp;ASTRAZENECA PLC: OVERVIEW

TABLE 33.&nbsp;&nbsp;&nbsp;ASTRAZENECA PLC: PRODUCT PORTFOLIO

TABLE 34.&nbsp;&nbsp;&nbsp;ASTRAZENECA PLC: KEY DEVELOPMENTS

TABLE 35.&nbsp;&nbsp;&nbsp;BAYER AG: OVERVIEW

TABLE 36.&nbsp;&nbsp;&nbsp;BAYER AG: PRODUCT PORTFOLIO

TABLE 37.&nbsp;&nbsp;&nbsp;BAYER AG: KEY DEVELOPMENTS

TABLE 38.&nbsp;&nbsp;&nbsp;BOEHRINGER INGELHEIM INTERNATIONAL GMBH: OVERVIEW

TABLE 39.&nbsp;&nbsp;&nbsp;BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO

TABLE 40.&nbsp;&nbsp;&nbsp;BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS

TABLE 41.&nbsp;&nbsp;&nbsp;F. HOFFMANN-LA ROCHE LTD.: OVERVIEW

TABLE 42.&nbsp;&nbsp;&nbsp;F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO

TABLE 43.&nbsp;&nbsp;&nbsp;F. HOFFMANN-LA ROCHE LTD.: KEY DEVELOPMENTS

TABLE 44.&nbsp;&nbsp;&nbsp;EISAI CO., LTD: OVERVIEW

TABLE 45.&nbsp;&nbsp;&nbsp;EISAI CO., LTD: PRODUCT PORTFOLIO

TABLE 46.&nbsp;&nbsp;&nbsp;EISAI CO., LTD: KEY DEVELOPMENTS

TABLE 47.&nbsp;&nbsp;&nbsp;EUROFARMA LABORAT&Oacute;RIOS S/A: OVERVIEW

TABLE 48.&nbsp;&nbsp;&nbsp;EUROFARMA LABORAT&Oacute;RIOS S/A: PRODUCT PORTFOLIO

TABLE 49.&nbsp;&nbsp;&nbsp;EUROFARMA LABORAT&Oacute;RIOS S/A: KEY DEVELOPMENTS

TABLE 50.&nbsp;&nbsp;&nbsp;PFIZER.: OVERVIEW

TABLE 51.&nbsp;&nbsp;&nbsp;PFIZER.: PRODUCT PORTFOLIO

TABLE 52.&nbsp;&nbsp;&nbsp;PFIZER.: KG: KEY DEVELOPMENTS

TABLE 53.&nbsp;&nbsp;&nbsp;NOVARTIS.: OVERVIEW

TABLE 54.&nbsp;&nbsp;&nbsp;NOVARTIS.: PRODUCT PORTFOLIO

TABLE 55.&nbsp;&nbsp;&nbsp;NOVARTIS.: KEY DEVELOPMENTS

TABLE 56.&nbsp;&nbsp;&nbsp;BRISTOL-MYERS SQUIBB: OVERVIEW

TABLE 57.&nbsp;&nbsp;&nbsp;BRISTOL-MYERS SQUIBB: PRODUCT PORTFOLIO

TABLE 58.&nbsp;&nbsp;&nbsp;BRISTOL-MYERS SQUIBB: KEY DEVELOPMENTS

TABLE 59.&nbsp;&nbsp;&nbsp;JOHNSON &amp; JOHNSON: OVERVIEW

TABLE 60.&nbsp;&nbsp;&nbsp;JOHNSON &amp; JOHNSON: PRODUCT PORTFOLIO

TABLE 61.&nbsp;&nbsp;&nbsp;JOHNSON &amp; JOHNSON: KEY DEVELOPMENTS

&nbsp;

<h3>List of Figures</h3>

FIGURE 01.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET SHARE, 2021 &amp; 2029 (%), BY PRODUCT TYPE

FIGURE 02.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET SHARE, 2021 &amp; 2029 (%), BY DISTRIBUTION CHANNEL

FIGURE 03.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET SHARE, 2021 &amp; 2029 (%), BY APPLICATION

FIGURE 04.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET SHARE, 2021 &amp; 2029 (%), BY REGION

FIGURE 05.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE, 2021 - 2029 AND YEAR ON YEAR GROWTH

FIGURE 06.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY PRODUCT TYPE

FIGURE 07&nbsp;&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE, BY RECEPTOR TYROSINE KINASE INHIBITOR, 2021&ndash;2029 ($MILLION)

FIGURE 08&nbsp;&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE, BY NON-RECEPTOR TYROSINE KINASE INHIBITORS, 2021&ndash;2029 ($MILLION)

FIGURE 09.&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY DISTRIBUTION CHANNEL

FIGURE 10&nbsp;&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY RETAIL PHARMACIES, 2021&ndash;2029 ($MILLION)

FIGURE 11&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY HOSPITAL PHARMACIES, 2021&ndash;2029 ($MILLION)

FIGURE 12&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY ONLINE STORES, 2021&ndash;2029 ($MILLION)

FIGURE 13&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY APPLICATION

FIGURE 14&nbsp;&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY CHRONIC MYELOID LEUKEMIA (CML), 2021&ndash;2029 ($MILLION)

FIGURE 15&nbsp;&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY LUNG CANCER, 2021&ndash;2029 ($MILLION)

FIGURE 16&nbsp;&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY BREAST CANCER, 2021&ndash;2029 ($MILLION)

FIGURE 17&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET VALUE , BY RENAL CELL CANCER, 2021&ndash;2029 ($MILLION)

FIGURE 18&nbsp;&nbsp;&nbsp;GLOBAL TYROSINE KINASE INHIBITORS MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY REGION

FIGURE 19&nbsp;&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 20&nbsp;&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 21&nbsp;&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

FIGURE 22&nbsp;&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 23&nbsp;&nbsp;&nbsp;&nbsp;NORTH AMERICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 24&nbsp;&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 25&nbsp;&nbsp;&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY PRODUCT PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 26&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

FIGURE 27&nbsp;&nbsp;&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 28&nbsp;&nbsp;&nbsp;&nbsp;SOUTH AMERICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 29&nbsp;&nbsp;&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 30&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY PRODUCT PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 31&nbsp;&nbsp;&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

FIGURE 32&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 33&nbsp;&nbsp;&nbsp;EUROPE TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 34&nbsp;&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 35&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY PRODUCT PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 36&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

FIGURE 37&nbsp;&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 38&nbsp;&nbsp;&nbsp;&nbsp;ASIA PACIFIC TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 39&nbsp;&nbsp;&nbsp;MIDDLE EAST AND AFRICA TYROSINE KINASE INHIBITORS MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 40&nbsp;&nbsp;&nbsp;&nbsp;MIDDLE EAST AND AFRICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY PRODUCT PRODUCT TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 41&nbsp;&nbsp;&nbsp;&nbsp;MIDDLE EAST AND AFRICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2021&ndash;2029 ($MILLION)

FIGURE 42&nbsp;&nbsp;&nbsp;&nbsp;MIDDLE EAST AND AFRICA TYROSINE KINASE INHIBITORS MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 43.&nbsp;&nbsp;&nbsp;ASTRAZENECA PLC: FINANCIALS

FIGURE 44.&nbsp;&nbsp;&nbsp;BAYER AG: FINANCIALS

FIGURE 45.&nbsp;&nbsp;&nbsp;BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIALS

FIGURE 46&nbsp;&nbsp;BRISTOL-MYERS SQUIBB: FINANCIALS

FIGURE 47.&nbsp;&nbsp;&nbsp;EISAI CO., LTD: FINANCIALS

FIGURE 48.&nbsp;&nbsp;&nbsp;EUROFARMA LABORAT&Oacute;RIOS S/A: FINANCIALS

FIGURE 49.&nbsp;&nbsp;&nbsp; PFIZER: FINANCIALS

FIGURE 50.&nbsp;&nbsp;&nbsp;NOVARTIS: FINANCIALS

FIGURE 51.&nbsp;&nbsp;&nbsp;F. HOFFMANN-LA ROCHE LTD..: FINANCIALS

FIGURE 52.&nbsp;&nbsp;&nbsp;JOHNSON &amp; JOHNSON: FINANCIALS